Patients with uveal melanoma may not experience symptoms in the early stages. As the tumor grows, symptoms can include blurred vision, a visible dark spot on the iris, changes in the shape of the pupil, or loss of peripheral vision. Some patients may experience flashes of light or floaters in their vision. In some cases, the tumor is discovered during a routine eye examination before symptoms develop.

The diagnostic workup for uveal melanoma typically begins with a comprehensive eye examination. This may include ophthalmoscopy, where a doctor uses a special lens to look inside the eye. Imaging tests such as ultrasound, fluorescein angiography, and optical coherence tomography (OCT) can help visualize the tumor. In some cases, a biopsy may be performed to confirm the diagnosis, although this is not always necessary.

Treatment for uveal melanoma depends on the size and location of the tumor, as well as the patient's overall health. Options include radiation therapy, which can be delivered through plaque brachytherapy or external beam radiation. Surgical options range from local resection of the tumor to enucleation, which is the removal of the eye, in severe cases. Laser therapy may also be used in certain situations. The goal is to preserve as much vision as possible while effectively treating the cancer.

The prognosis for uveal melanoma varies based on several factors, including the size and location of the tumor and whether it has spread beyond the eye. Smaller tumors that are detected early generally have a better prognosis. However, uveal melanoma can metastasize, most commonly to the liver, which significantly worsens the outlook. Regular follow-up is crucial to monitor for any signs of metastasis.

The exact cause of uveal melanoma is not well understood. However, several risk factors have been identified, including fair skin, light eye color, and certain genetic mutations. Exposure to ultraviolet (UV) light is a known risk factor for skin melanoma, but its role in uveal melanoma is less clear. Some studies suggest a possible link, but more research is needed.

Uveal melanoma is a rare condition, with an incidence of approximately 5 to 6 cases per million people per year. It is more common in individuals of Caucasian descent and is rare in people with darker skin. The average age of diagnosis is around 60 years, and it affects men and women equally.

Uveal melanoma arises from melanocytes, the pigment-producing cells in the uvea. Genetic mutations in these cells can lead to uncontrolled growth and tumor formation. Common mutations involve genes such as GNAQ, GNA11, and BAP1. The tumor can invade local structures within the eye and has the potential to spread to distant organs, particularly the liver.

There are no specific measures to prevent uveal melanoma, but regular eye examinations can help detect the disease early. Protecting the eyes from excessive UV exposure by wearing sunglasses may be beneficial, although the link between UV light and uveal melanoma is not definitively established. Awareness of personal risk factors, such as family history and skin type, can also aid in early detection.

Uveal melanoma is a rare eye cancer that requires prompt attention due to its potential to spread. It often presents with subtle symptoms, making regular eye exams crucial for early detection. Treatment options vary based on the tumor's characteristics and aim to preserve vision while controlling the disease. Understanding the risk factors and maintaining regular follow-up can improve outcomes for those affected.

If you or someone you know is experiencing changes in vision or has been diagnosed with uveal melanoma, it's important to understand the condition and the available treatment options. Uveal melanoma is a type of eye cancer that can affect vision and may spread to other parts of the body. Early detection through regular eye exams is key to managing the disease effectively. Treatment may involve radiation, surgery, or laser therapy, depending on the specific case. Regular follow-up with healthcare providers is essential to monitor for any changes or spread of the cancer.